Study ID: COG ARST0921
Description:
A Randomized Phase II Trial of Bevacizumab (IND #7921, Avastin) and Temsirolimus (IND# 61010, Torisel) in Combination with Intravenous Vinorelbine and Cyclophosphamide in Patients with Recurrent/Refractory Rhabdomyosarcoma
Location:
Sioux Falls Region
Principal Investigator:
Kayelyn Wagner MD
Disease:
RST (Soft Tissue Sarcoma)
Stage:
Phase II
Status:
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.
Back to Clinical Trials list